Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasone

EM Myklebust, F Schjesvold, A Frigessi, K Leder, J Foo… - medRxiv, 2024 - medrxiv.org
Multiple myeloma (MM) patients experience repeated cycles of treatment response and
relapse, yet despite close monitoring of disease status through M protein measurements, no …

Prediction of cancer dynamics under treatment using Bayesian neural networks: A simulated study

EM Myklebust, A Frigessi, F Schjesvold, J Foo… - arXiv preprint arXiv …, 2024 - arxiv.org
Predicting cancer dynamics under treatment is challenging due to high inter-patient
heterogeneity, lack of predictive biomarkers, and sparse and noisy longitudinal data …